"Amyris has not only a break-through technology but a clearly defined strategy to commercialize a promising slate of next-generation biofuels that could have a profound impact on the transportation market," said R. Thomas Goodrich at DAG Ventures. "We are investing with strong confidence in what Amyris is creating as well as the management and scientific team the company is putting in place to execute on its vision."

"No-compromise transportation fuels derived from renewable sources hold substantial promise for meeting the tremendous need for alternative energy sources in the future," said John Melo, CEO of Amyris. "We have already succeeded in creating these biofuels in our lab. We are delighted with the strong interest in our Series B funding which will enable us to continue the research and scale-up of our technology and to implement our business model as the first biofuels company to go from production to customer."

"Amyris is designing better biofuels from designer bugs" said John Doerr, partner at Kleiner Perkins Caufield & Byers. "This is a big deal because Amyris' cost competitive biofuels will work with existing engines without compromising performance and will have a lower carbon footprint. This financing will help Amyris scale with speed." Amyris expects to close the second tranche of its Series B financing by the end of 2007.